SCHEMBL6157294

SCHEMBL6157294

COC(=O)N[C@H](C(=O)NC(Cc1ccccc1)C(O)CN(N)Cc1ccc(-c2cncs2)cc1)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLNR O43193 2/20 0.47
NR1I2 O75469 2/20 0.47
SLCO2B1 O94956 2/20 0.47
ABCB11 O95342 2/20 0.47
ABCB1 P08183 2/20 0.47
UGT1A1 P22309 2/20 0.47
CCKAR P32238 2/20 0.47
OPRK1 P41145 2/20 0.47
GHSR Q92847 2/20 0.47
SLCO1B3 Q9NPD5 2/20 0.47
ABCG2 Q9UNQ0 2/20 0.47
SLCO1B1 Q9Y6L6 2/20 0.47
PSEN1 P49768 3/20 0.44
PSEN2 P49810 3/20 0.44
APH1B Q8WW43 3/20 0.44
NCSTN Q92542 3/20 0.44
APH1A Q96BI3 3/20 0.44
PSENEN Q9NZ42 3/20 0.44
CYP3A4 P08684 5/20 0.43
CYP2D6 P10635 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6105 1.00 MLNR (0.47) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL5960 0.94 MLNR (0.43) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6156660 0.94 MLNR (0.43) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6298 0.91 UGT1A1 (0.59) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7543485 0.88 PSEN1 (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7543483 0.88 PSEN1 (0.52) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL7397 0.86 UGT1A1 (0.56) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6157340 0.86 UGT1A1 (0.56) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6185 0.86 UGT1A1 (0.54) MLNRNR1I2SLCO2B1ABCB11ABCB1
SCHEMBL6550 0.86 UGT1A1 (0.54) MLNRNR1I2SLCO2B1ABCB11ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0900210-B1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 2005-02-09 EP disclosed
US-6300519-B1 REACTING HYDRAZINE DERIVATIVE WITH EPOXIDE COMPOUND NOVARTIS FINANCE CORPORATION 2001-10-09 US disclosed
US-6166004-A Combinations of HIV protease inhibitors with reverse transcriptase inhibitors NOVARTIS FINANCE CORPORATION (US) 2000-12-26 US disclosed
US-6110946-A AN ENZYME INHIBITORS OF RETROVIRAL ASPARTATE PROTEASE FOR THE TREATMENT OF AIDS NOVARTIS FINANCE CORPORATION (US) 2000-08-29 US disclosed
EP-0900210-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES Novartis AG (CH) 1999-03-10 EP disclosed
WO-1997040029-A1 ANTIVIRALLY ACTIVE HETEROCYCLIC AZAHEXANE DERIVATIVES NOVARTIS AG (CH) 1997-10-30 WO disclosed